DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) today announced that the Company will report its financial results for the fourth quarter and full-year 2015, on Wednesday, March 23, 2016 prior to a conference call with the investment community scheduled at 8:00 a.m. ET.
